GoodRx Holdings (GDRX) Retained Earnings (2019 - 2026)
GoodRx Holdings' Retained Earnings history spans 7 years, with the latest figure at -$1.4 billion for Q4 2025.
- On a quarterly basis, Retained Earnings rose 2.11% to -$1.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.4 billion, a 2.11% increase, with the full-year FY2025 number at -$1.4 billion, up 2.11% from a year prior.
- Retained Earnings hit -$1.4 billion in Q4 2025 for GoodRx Holdings, roughly flat from -$1.4 billion in the prior quarter.
- Over the last five years, Retained Earnings for GDRX hit a ceiling of -$1.4 billion in Q2 2021 and a floor of -$1.5 billion in Q1 2024.
- Historically, Retained Earnings has averaged -$1.4 billion across 5 years, with a median of -$1.4 billion in 2025.
- Biggest five-year swings in Retained Earnings: dropped 25.97% in 2021 and later grew 2.38% in 2025.
- Tracing GDRX's Retained Earnings over 5 years: stood at -$1.4 billion in 2021, then dropped by 2.32% to -$1.4 billion in 2022, then decreased by 0.61% to -$1.5 billion in 2023, then increased by 1.12% to -$1.4 billion in 2024, then grew by 2.11% to -$1.4 billion in 2025.
- Business Quant data shows Retained Earnings for GDRX at -$1.4 billion in Q4 2025, -$1.4 billion in Q3 2025, and -$1.4 billion in Q2 2025.